FDA's Final Batch of Pfizer Vaccine Documents: Transparency Challenges and Safety Concerns

"Insights into Pfizer's Comirnaty Approval and Safety Oversight Raise Questions on Vaccine Monitoring and Disclosure"

The FDA has finally unveiled the conclusive set of documents that served as the basis for granting Pfizer's Comirnaty COVID-19 vaccine approval for individuals aged 16 and above. This disclosure, occurring more than 800 days after the shot's initial approval, marks a significant move toward public transparency.